Nurtec

NICE gives thumbs-up to Pfizer's migraine drug—but with lots of restrictions
NICE gives thumbs-up to Pfizer's migraine drug—but with lots of restrictions
Fierce Pharma
Biohaven
Pfizer
migraines
NICE
Nurtec
Vydura
Flag link:
AbbVie touts Qulipta chronic migraine win as Biohaven duel heats up
AbbVie touts Qulipta chronic migraine win as Biohaven duel heats up
Fierce Pharma
AbbVie
Biohaven
migraines
Qulipta
Nurtec
Flag link:
Biohaven points up Nurtec dual-migraine approval with growing stable of celebrity users
Biohaven points up Nurtec dual-migraine approval with growing stable of celebrity users
Fierce Pharma
Biohaven Pharmaceuticals
migraines
celebrity endorsements
Nurtec
digital advertising
DTC advertising
Flag link:
Biohaven CEO on migraine drug's fast launch, TikTok ads and battling big pharma
Biohaven CEO on migraine drug's fast launch, TikTok ads and battling big pharma
BioPharma Dive
Biohaven
migraines
drug launches
DTC advertising
Nurtec
Flag link:
Why Glaxo should buy Biohaven
Why Glaxo should buy Biohaven
EP Vantage
Biohaven
GSK
Nurtec
migraines
M&A
Flag link:
Biohaven Leaps After Posting $93M Sales for Migraine Drug
Biohaven Leaps After Posting $93M Sales for Migraine Drug
TheStreet.com
Biohaven
migraines
Nurtec
Flag link:
Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to-head study
Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to-head study
Fierce Pharma
Eli Lilly
Emgality
migraines
Biohaven
Nurtec
Flag link:
Biohaven earns preventative nod for migraine med Nurtec, snaring a much-needed leg up over AbbVie
Biohaven earns preventative nod for migraine med Nurtec, snaring a much-needed leg up over AbbVie
Endpoints
Biohaven
FDA
migraines
Nurtec
AbbVie
Flag link:
Another Kardashian FDA letter: Biohaven smacked for Khloe's Nurtec migraine med claims
Another Kardashian FDA letter: Biohaven smacked for Khloe's Nurtec migraine med claims
Fierce Pharma
Biohaven
Nurtec
celebrity endorsements
FDA
Flag link:
Biohaven adds nearly $1B in Nurtec deals with Royalty Pharma, Sixth Street
Biohaven adds nearly $1B in Nurtec deals with Royalty Pharma, Sixth Street
Endpoints
Biohaven
Nurtec
Royalty Pharma
Sixth Street
Flag link:
AbbVie preps a challenge to a rival migraine drug from Biohaven, spelling out an upbeat set of PhIII data
AbbVie preps a challenge to a rival migraine drug from Biohaven, spelling out an upbeat set of PhIII data
Endpoints
AbbVie
migraine
Nurtec
atogepant
Biohaven
Flag link:
Biohaven embraces digital to keep migraine launch on track despite COVID-19
Biohaven embraces digital to keep migraine launch on track despite COVID-19
Fierce Pharma
Biohaven
migraines
drug launches
digital pharma
COVID-19
pandemic
Nurtec
Flag link:
Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?
Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?
Endpoints
Biohaven
FDA
migraines
Nurtec
Allergan
AbbVie
Ubrelvy
Flag link: